168 related articles for article (PubMed ID: 30539837)
41. MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells.
Chandimali N; Huynh DL; Zhang JJ; Lee JC; Yu DY; Jeong DK; Kwon T
Cancer Gene Ther; 2019 Sep; 26(9-10):292-304. PubMed ID: 30341415
[TBL] [Abstract][Full Text] [Related]
42. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9.
Kong YJ; Tan XX; Zhang Y; He QJ; Zhao L; Meng Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10370-10378. PubMed ID: 31841191
[TBL] [Abstract][Full Text] [Related]
43. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction.
Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G
Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462
[TBL] [Abstract][Full Text] [Related]
44. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-1197 downregulation inhibits proliferation and migration in human non- small cell lung cancer cells by upregulating HOXC11.
Sun B; Hua J; Cui H; Liu H; Zhang K; Zhou H
Biomed Pharmacother; 2019 Sep; 117():109041. PubMed ID: 31181445
[TBL] [Abstract][Full Text] [Related]
46. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
Liao Y; Cao L; Wang F; Pang R
J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
[TBL] [Abstract][Full Text] [Related]
47. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
Hao C; Liu G; Tian G
Ther Adv Respir Dis; 2019; 13():1753466619866097. PubMed ID: 31368411
[TBL] [Abstract][Full Text] [Related]
48. miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5.
Wang Y; Xu L; Jiang L
Biochem Biophys Res Commun; 2015 Mar; 458(3):714-719. PubMed ID: 25686496
[TBL] [Abstract][Full Text] [Related]
49. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
50. Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer.
Zhang J; Zhang C; Hu L; He Y; Shi Z; Tang S; Chen Y
Cancer Invest; 2015 May; 33(5):165-71. PubMed ID: 25831148
[TBL] [Abstract][Full Text] [Related]
51. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
[TBL] [Abstract][Full Text] [Related]
52. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
53. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
54. Silent FOSL1 Enhances the Radiosensitivity of Glioma Stem Cells by Down-Regulating miR-27a-5p.
Li R; Che W; Liang N; Deng S; Song Z; Yang L
Neurochem Res; 2021 Dec; 46(12):3222-3246. PubMed ID: 34420141
[TBL] [Abstract][Full Text] [Related]
55. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
56. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
57. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M
Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
[TBL] [Abstract][Full Text] [Related]
58. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
Wang P; Lv HY; Zhou DM; Zhang EN
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
[TBL] [Abstract][Full Text] [Related]
60. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
